Joerg Striessnig

Citée par

	Toutes	Depuis 2020
Citations	28573	8015
indice h	88	45
indice i10	202	107

1900

950

475

1425

19871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202591 236 220 170 197 237 276 275 239 267 345 370 317 382 339 394 432 611 735 702 831 696 725 851 915 1032 1025 1157 1149 1071 1290 1320 1370 1523 1805 1621 1456 1337 266

Accès public

Tout afficher

101 articles

3 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Hartmut GlossmannFull Professor M.D. PhD. Qualified Specialist In Pharmacology,Toxicology and Clinical PharmacologyAdresse e-mail validée de i-med.ac.at
Matteo Elia MANGONIDirecteur de Recherche CNRS, Institut de Génomique Fonctionnelle, Université de MontpellierAdresse e-mail validée de igf.cnrs.fr
Hans-Günther KnausMedizinische Universität InnsbruckAdresse e-mail validée de i-med.ac.at
Nicolas SingewaldDepartment of Pharmacology & Toxicology, Univ of InnsbruckAdresse e-mail validée de uibk.ac.at
Petronel TulucAssoc. Prof. Dep. Pharmacology and Toxicology, Innsbruck UniversityAdresse e-mail validée de uibk.ac.at
Edward Perez-ReyesProfessor of Pharmacology, University of VirginiaAdresse e-mail validée de virginia.edu
Emilio CarboneProfessor of Physiology, Department of Drug Science, University of TorinoAdresse e-mail validée de unito.it
Anneliese Schrott-FischerMedical University of InnsbruckAdresse e-mail validée de i-med.ac.at
Prof David R. FerryVP-Gastrointestinal OncologyAdresse e-mail validée de lilly.com
Emmanuel BourinetIGFUniversité de Montpellier CNRS UMR5203 Inserm U1191Adresse e-mail validée de igf.cnrs.fr
Gerald ZernigAssoc Prof Pharmacol Toxicol, MD, Psychotherapist, Medical University of InnsbruckAdresse e-mail validée de zerniglabor.at
Christoph RomaninProfessor of Biophysics, Johannes Kepler University LinzAdresse e-mail validée de jku.at
Annette C DolphinProfessor of Pharmacology, University College LondonAdresse e-mail validée de ucl.ac.uk
Simone SartoriUniversity of InnsbruckAdresse e-mail validée de uibk.ac.at
Stefan HerzigAlt-Präsident TH Köln, Professor emeritus für Pharmakologie, Universität zu KölnAdresse e-mail validée de uni-koeln.de
Tobias MoserInstitute for Auditory Neuroscience, University Medical Center GöttingenAdresse e-mail validée de gwdg.de
Thierry LangerUniversity of Innsbruck, University of ViennaAdresse e-mail validée de univie.ac.at
Sebastian BargMedical Cell Biology, Uppsala UniversityAdresse e-mail validée de mcb.uu.se
Eckhard FriaufSenior Professor of Animal Physiology - Neurobiology; RPTU Kaiserslautern-LandauAdresse e-mail validée de biologie.uni-kl.de
paola carreraGroup Leader, Ospedale San Raffaele, MilanoAdresse e-mail validée de hsr.it

Suivre

Joerg Striessnig

University of Innsbruck, Austria

Adresse e-mail validée de uibk.ac.at - Page d'accueil

Ion Channel Pharmacology Calcium Signaling Calcium Channels


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels WA Catterall, E Perez-Reyes, TP Snutch, J Striessnig Pharmacological reviews 57 (4), 411-425, 2005	1710	2005
The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential GW Zamponi, J Striessnig, A Koschak, AC Dolphin Pharmacological reviews 67 (4), 821-870, 2015	1170	2015
Purification, molecular cloning, and expression of the mammalian sigma1-binding site. M Hanner, FF Moebius, A Flandorfer, HG Knaus, J Striessnig, E Kempner, ... Proceedings of the National Academy of Sciences 93 (15), 8072-8077, 1996	1146	1996
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels J Platzer, J Engel, A Schrott-Fischer, K Stephan, S Bova, H Chen, ... Cell 102 (1), 89-97, 2000	1099	2000
Neurobiology of migraine D Pietrobon, J Striessnig Nature Reviews Neuroscience 4 (5), 386-398, 2003	814	2003
Functional role of L-type Ca_v1.3 Ca²⁺ channels in cardiac pacemaker activity ME Mangoni, B Couette, E Bourinet, J Platzer, D Reimer, J Striessnig, ... Proceedings of the National Academy of Sciences 100 (9), 5543-5548, 2003	598	2003
α1D (Cav1. 3) subunits can form L-type Ca2+ channels activating at negative voltages A Koschak, D Reimer, I Huber, M Grabner, H Glossmann, J Engel, ... Journal of Biological Chemistry 276 (25), 22100-22106, 2001	566	2001
Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension EAB Azizan, H Poulsen, P Tuluc, J Zhou, MV Clausen, A Lieb, C Maniero, ... Nature genetics 45 (9), 1055-1060, 2013	564	2013
Pharmacological disruption of calcium channel trafficking by the α2δ ligand gabapentin J Hendrich, AT Van Minh, F Heblich, M Nieto-Rostro, K Watschinger, ... Proceedings of the National Academy of Sciences 105 (9), 3628-3633, 2008	517	2008
CaV1. 3 channels are essential for development and presynaptic activity of cochlear inner hair cells A Brandt, J Striessnig, T Moser Journal of Neuroscience 23 (34), 10832-10840, 2003	486	2003
Receptor sites for Ca2+ channel antagonists WA Catterall, J Striessnig Trends in pharmacological sciences 13, 256-262, 1992	479	1992
The Concise Guide to PHARMACOLOGY 2019/20: Introduction and other protein targets SPH Alexander, E Kelly, A Mathie, JA Peters, EL Veale, JF Armstrong, ... British journal of pharmacology 176, S1-S20, 2019	444	2019
Functional embryonic cardiomyocytes after disruption of the L-type α1C (Cav 1.2) calcium channel gene in the mouse C Seisenberger, V Specht, A Welling, J Platzer, A Pfeifer, S Kühbandner, ... Journal of Biological Chemistry 275 (50), 39193-39199, 2000	386	2000
Loss of Ca_v1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness SM Baig, A Koschak, A Lieb, M Gebhart, C Dafinger, G Nürnberg, A Ali, ... Nature neuroscience 14 (1), 77-84, 2011	378	2011
The concise guide to pharmacology 2017/18: overview SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ... British journal of pharmacology 174, S1-S16, 2017	372	2017
The concise guide to pharmacology 2019/20: Ion channels SPH Alexander, A Mathie, JA Peters, EL Veale, J Striessnig, E Kelly, ... British journal of pharmacology 176, S142-S228, 2019	368	2019
International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels WA Catterall, J Striessnig, TP Snutch, E Perez-Reyes Pharmacological reviews 55 (4), 579-581, 2003	362	2003
Familial hemiplegic migraine mutations increase Ca²⁺ influx through single human Ca_V2.1 channels and decrease maximal Ca_V2.1 current density in neurons A Tottene, T Fellin, S Pagnutti, S Luvisetto, J Striessnig, C Fletcher, ... Proceedings of the National Academy of Sciences 99 (20), 13284-13289, 2002	352	2002
Quantitative proteomics of the Cav2 channel nano-environments in the mammalian brain CS Müller, A Haupt, W Bildl, J Schindler, HG Knaus, M Meissner, ... Proceedings of the National Academy of Sciences 107 (34), 14950-14957, 2010	345	2010
Familial Hemiplegic Migraine Mutations Change α1ACa2+ Channel Kinetics RL Kraus, MJ Sinnegger, H Glossmann, S Hering, J Striessnig Journal of Biological Chemistry 273 (10), 5586-5590, 1998	339*	1998

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs